SCHEMBL541696

SCHEMBL541696

CC(C)CCc1nc2[nH]c(=O)[nH]c(=O)c2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
HCAR2 Q8TDS4 2/20 0.40
HCAR3 P49019 1/20 0.40
ADORA2B P29275 1/20 0.40
XDH P47989 3/20 0.38
GPR84 Q9NQS5 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 1/20 0.36
SORT1 Q99523 1/20 0.36
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
PDE5A O76074 1/20 0.35
ACHE P22303 1/20 0.35
GDA Q9Y2T3 1/20 0.35
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
XBP1 P17861 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60159 0.83 TSHR (0.46) MAPTADORA2BXDHTSHRACHE
SCHEMBL1150739 0.81 XDH (0.47) MAPTHCAR2ADORA2BXDHACHE
SCHEMBL9429870 0.81 PDE3B (0.39) MAPTHCAR2HCAR3ADORA2BXDH
SCHEMBL9430321 0.80 XDH (0.39) MAPTHCAR2HCAR3ADORA2BXDH
SCHEMBL9431012 0.80 XDH (0.39) MAPTHCAR2HCAR3ADORA2BXDH
SCHEMBL6233162 0.79 XDH (0.51) MAPTHCAR2HCAR3ADORA2BXDH
SCHEMBL7530553 0.78 MAPT (0.46) MAPTADORA2BXDHPDE3BPDE3A
SCHEMBL380136 0.78 MAPT (0.48) MAPTHCAR2ADORA2BXDHACHE
SCHEMBL8700368 0.77 MAPT (0.42) MAPTADORA2BXDHTSHRPDE3B
SCHEMBL7326964 0.77 MAPT (0.42) MAPTHCAR2ADORA2BXDHTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3089732-B1 CONTROLLED RELEASE FATTY ACID COMPOSITIONS FOR USE IN BODY RECONSTRUCTION AND BODY-SHAPING PB&B SA (CH) 2023-09-27 EP claimed
EP-3385372-B1 METHOD FOR MANUFACTURING MESENCHYMAL CELL LINE DERIVED FROM VERTEBRATE ANIMAL ADIPOSE TISSUE ADIPOSEEDS INC (JP) 2023-08-09 EP claimed
EP-2726603-B1 BROWN FAT CELL COMPOSITIONS AND METHODS BIORESTORATIVE THERAPIES INC (US) 2020-04-01 EP claimed
US-20190175655-A1 DRY PLATELET COMPOSITION LIFECELL CORPORATION 2019-06-13 US claimed
EP-3019599-B1 METHOD FOR ISOLATING STROMAL VASCULAR FRACTION AGENCY SCIENCE TECH & RES (SG) 2018-06-13 EP claimed
EP-1929289-B1 DRY PLATELET COMPOSITION LIFECELL CORP (US) 2018-02-21 EP claimed
EP-2670841-B1 NOVEL METHOD FOR THE PRODUCTION OF DIFFERENTIATED RESPIRATORY EPITHELIAL CELLS MEDIZINISCHE HOCHSCHULE HANNOVER (DE) 2017-11-22 EP claimed
EP-2603227-B1 IMPROVED HEMATOPOIETIC STEM AND PROGENITOR CELL THERAPY FATE THERAPEUTICS INC (US) 2017-10-04 EP claimed
US-20170136064-A1 Dry Platelet Composition LIFECELL CORPORATION (US) 2017-05-18 US claimed
CN-106243175-A Method for preparing novel crystal form of emamectin benzoate and application thereof 龙灯农业化工国际有限公司 2016-12-21 CN claimed
US-5700369-A Process for adsorboaggregational flotation of Carlin type natural gold ore dressing GUANGZHOU INSTITUTE OF GEOCHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 1997-12-23 US claimed
EP-0706369-B1 STIMULATION OF TANNING BY DNA FRAGMENTS UNIV BOSTON (US) 1997-12-17 EP claimed
WO-1997030350-A1 PROLONGED PRESERVATION OF BLOOD PLATELETS LIFECELL CORPORATION (US) 1997-08-21 WO claimed
EP-0786934-A2 PROLONGED PRESERVATION OF BLOOD PLATELETS LIFECELL CORPORATION (US) 1997-08-06 EP claimed
WO-1996013158-A2 PROLONGED PRESERVATION OF BLOOD PLATELETS LIFECELL CORPORATION (US) 1996-05-09 WO claimed
US-5476651-A Applying to cause melanogenesis; solvent extraction LVMH RECHERCHE (FR) 1995-12-19 US claimed
EP-0455682-B1 POLYPEPTIDES HAVING A HUMAN BETA-ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES CENTRE NAT RECH SCIENT (FR) 1993-12-29 EP claimed
EP-0308460-B1 A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION Kabi Pharmacia AB (SE) 1992-07-29 EP claimed
EP-0455682-A1 POLYPEPTIDES HAVING A HUMAN BETA-ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES. CENTRE NAT RECH SCIENT (FR) 1991-11-13 EP claimed
WO-1990008775-A1 POLYPEPTIDES HAVING A HUMAN β ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1990-08-09 WO claimed